Medication adherence to lipid-lowering agents after percutaneous coronary intervention: nationwide real-world data in the Netherlands
This study found lipid-lowering medication adherence 1 year post-elective PCI ranged from 71-73% and post-acute PCI from 74-76%. Lower adherence rates were observed in women and elderly patients. Adherence rates of ezetimibe and PCSK9 inhibitors increased throughout the year following PCI, while statin use decreased.
Authors
- Jan Reitsma (ORCID: https://orcid.org/0000-0002-2919-8626)
- Peter W. Danse (ORCID: https://orcid.org/0000-0002-6240-361X)
- Judith A. van Erkelens (ORCID: https://orcid.org/0000-0002-2549-9659)
- Pieter W. Kamphuisen (ORCID: https://orcid.org/0000-0002-6263-0177)
- Cyril Camaro
- M J C Timmermans
- E. Karin Arkenbout
- M. Patrick Witvliet
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Netherlands Heart Registration (NL)
- Tergooi (NL)
- Zorgverzekeraars Nederland (NL)
- Rijnstate Hospital (NL)
- Stichting tot Steun VCVGZ (NL)
Publication Details
- Journal
- Netherlands Heart Journal
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1007/s12471-026-02028-8
- Citations
- 1
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 44.68